Chris Hibberd | GenomeWeb

Chris Hibberd

Chris Hibberd has joined the board of directors of Oxford Genome Sciences. Hibberd is currently CEO of Astute Medical and is a former senior vice president of corporate development for Biosite. Prior to joining Biosite, he was a manager at the Boston Consulting Group.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.